Navigation Links
Examination of internal 'wiring' of yeast, worm, and fly reveals conserved circuits

ormation could help modify that approach to drug discovery. "Maybe the target protein has a good and necessary role in 10 interactions, but the 11th is the only one we would need to eliminate," said Ideker. "What we really want are drugs that interfere with just that one disease-causing interaction."

Systems biologists such as Ideker say their ultimate goal is a comprehensive computer model of how cells work. A description of all protein-interaction circuits would make such a model possible. "We'd like to simulate diseased cell types, such as cancer cells, and then simulate the effects of drugs on those diseased cells," said Ideker. "Ultimately, we think this kind of a systems biology approach will have a very beneficial impact on drug design and human health."


'"/>

Source:University of California - San Diego


Page: 1 2 3 4

Related biology news :

1. New GI technologies improve internal organ visualization
2. UCSD researchers discover internal compass of immune cell
3. Researchers create artificial enzyme that mimics the bodys internal engine
4. From a lowly yeast, researchers divine a clue to human disease
5. A bacterial genome reveals new targets to combat infectious disease
6. First real-time view of developing neurons reveals surprises, say Stanford researchers
7. NYU study reveals how brains immune system fights viral encephalitis
8. Study reveals new technique for fingerprinting environmental samples
9. Study reveals dramatic difference between breast cancers in US and Africa
10. UCSD research reveals mechanism involved with type of fatal epilepsy
11. Study reveals candidate targets for anti-retroviral therapeutics

Post Your Comments:
(Date:11/3/2009)... from the UCLA Henry Samueli School of Engineering...ssfully reconstituted in the laboratory the enzyme...erol-lowering drug lovastatin. , The research...d potentially lead to the development of other com...he lovastatin-synthesizing enzyme is one of the mo...
(Date:11/3/2009)...NCISCO, Nov. 3 EmSense Corporation...iological and brainwave measurement technology, to...s C round of funding, led by an investment from Te...ry Group also participating. ,, This funding wi...in support of its many market research partners. ...
(Date:11/2/2009)...I, OCTOBER 27, 2009 Agriculture is going through...strial revolution of the 19th century and the gree...ors of a new book, Organic Farming: The Ecologica...sdom with the best that science has to offer. The ...nd how organic systems can be designed to meet hum...
Breaking Biology News(10 mins):UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 2EmSense Raises $9 Million Series C Round of Financing 2Ecology in organic ag: Combining farming, science 2Media registration for ECCO 15 ESMO 34 multidisciplinary cancer congress 56392 1Media registration for ECCO 15 ESMO 34 multidisciplinary cancer congress 56392 2Media registration for ECCO 15 ESMO 34 multidisciplinary cancer congress 56392 3Organic weed control for dandelions 9824 1Organic weed control for dandelions 9824 2PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director 13901 1PriceSpective Appoints Colasante as a Vice President and Murdoch as a Director 13901 2
...man is taking nanocrystal research to a new level ...better computer printer ink. , The assistant prof...rtment of the College of Natural Resources at Virg...merican Chemical Society 233rd National Meeting an...of her research deals with cellulose drug delivery...
...ers at Johns Hopkins have discovered to their surp...ngus can also block angiogenesis, the growth of ne..., itraconazole, already is FDA approved for human ...ntiangiogenesis drug. , In mice induced to have e...zole reduced blood vessel growth by 67 percent com...
...all fruit flies buzzing around your bananas are mo...rch for clues to human diseases caused when genes ...ndividual humans may carry ,disease-causing, genes...son, a biology professor at Texas A&M Universi...al genes have different forms, called alleles, som...
Other Biology News:Anti-fungal drug stops blood vessel growth 2Fruit fly gene research may shed light on human disease processes 2Fruit fly gene research may shed light on human disease processes 3
(Date:11/4/2009)...nthrax Vaccine Program must be stopped. Scott Mil...ot;A Call to Arms:2009 Edition" and the one-h...he Human Anthrax Vaccine Story" to inform the...secret government science turned into for-profit h...s victims. It is available for world-wide licensi...
(Date:11/4/2009)...ewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq:...the third quarter ended September 30, 2009. ,,... improved to $31.0 million or $0.33 per share, as ...er share in the third quarter of 2008. ,, Ne...ng efficiencies as compared to a year ago. Total ...
(Date:11/4/2009)...wire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE ...ucts for regenerative healing, announced today tha...ment with Community Tissue Services (CTS), with an...nt replaces an existing contract between the two c...der the terms of the agreement, CTS will supply Os...
(Date:11/4/2009)...n situ FTIR analysis has become a standard tool in...oviding information rich data that allows a more t...lopment and scale-up of chemical processes. METTL...e Development of Batch and Continuous Chemical Pro... Process Analytical Technology (PAT) Tool on Novem...
Breaking Biology Technology:Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 2Nektar Therapeutics Reports Third Quarter 2009 Financial Results 3Nektar Therapeutics Reports Third Quarter 2009 Financial Results 4Nektar Therapeutics Reports Third Quarter 2009 Financial Results 5Nektar Therapeutics Reports Third Quarter 2009 Financial Results 6Nektar Therapeutics Reports Third Quarter 2009 Financial Results 7Nektar Therapeutics Reports Third Quarter 2009 Financial Results 8Nektar Therapeutics Reports Third Quarter 2009 Financial Results 9Nektar Therapeutics Reports Third Quarter 2009 Financial Results 10Osteotech Secures 10-Year Tissue Supply Agreement 2Osteotech Secures 10-Year Tissue Supply Agreement 3Development of Batch and Continuous Chemical Processes Using Real-Time In Situ FTIR Analytics as a Process Analytical Technology (PAT) Tool 2
... Receives Exercise Fee of $50 Million , , Cytokin...009 at 9 AM ET , , SOUTH SAN FRANCISCO, Calif. a...orporated (Nasdaq: CYTK ) and Amgen Inc. (Nasdaq...d its option to obtain an exclusive license, world...ontractility program. The license includes CK-182...
... May 26 Elsevier ,s Science &,Technology divi...hey will,jointly organize the first "Attracting Ac...at the Beijing Rongjin International Hotel. , ...d high-level capacities,in science and technology ...,academic talent among universities is a topic of ...
...26 Russia has been looked upon as an unfavourable...lectronics manufacturers in the past. This negativ...st-competitive advantages as well as its growing d...th heightened demand from key end-user segments su... the electronics manufacturing market in Russia. ,...
Other Biology Technology:Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452 2Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452 3Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452 4Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452 5Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452 6Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452 7Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452 8Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452 9Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452 10Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452 11Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452 12Elsevier's Science & Technology Division and Science News Partner to Organize the First "Attracting Academic Talent Summit" in Beijing 2Elsevier's Science & Technology Division and Science News Partner to Organize the First "Attracting Academic Talent Summit" in Beijing 3Frost & Sullivan: Lower Import Duties and Rising Customer Demand to Boost Russian Electronics Manufacturing Market 2Frost & Sullivan: Lower Import Duties and Rising Customer Demand to Boost Russian Electronics Manufacturing Market 3
Rabbit Anti-JTB Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Mouse Anti-Human NPM Monoclonal Antibody, Unconjugated, Clone 5E3 from AbD Serotec
Pyrophosphate Colorimetric / Fluorometric (resorufin) Assay Kit, PiPer from Molecular Probes (Invitrogen)
Captivate magnetic separator for six microtubes from Molecular Probes (Invitrogen)
Biology Products: